OBJECTIVE: We examined factors associated with in-hospital death among children with tuberculosis (TB). We hypothesized that a negative response to tuberculin skin testing (TST) would predict decreased survival. METHODS: This retrospective cohort comprised 2392 children ages 0 to 14 years hospitalized with TB at a Peruvian referral hospital over the 25-year study period. Detailed chart abstraction captured clinical history including TB contacts, physical examination findings, diagnostic data, treatment regimen, and hospitalization outcome. We used Cox proportional hazards regression analyses to determine risk factors for mortality. RESULTS: Of 2392 children, 2 (0.1%) were known to be HIV-positive, 5 (0.2%) had documented multidrug-resistant TB, and 266 (11%) died. The median time from hospitalization to death was 16 days (interquartile range: 4-44 days). Reaction of <5 mm induration on TST predicted death in a multivariable analysis (hazard ratio [HR]: 3.01; 95% confidence interval [CI]: 2.15-4.21; P < .0001). Younger age, period of admission, alteration of mental status (HR: 3.25; 95% CI: 2.48-4.27; P < .0001), respiratory distress (HR: 1.40; 95% CI: 1.07-1.83; P = .01), peripheral edema (HR: 1.97; 95% CI: 1.42-2.73; P < .0001), and hemoptysis (HR: 0.57; 95% CI: 0.32-1.00; P = .05) were associated with mortality. Treatment regimens that contained rifampicin (HR: 0.47; 95% CI: 0.33-0.68; P < .0001) were associated with improved survival. CONCLUSIONS: Negative reaction to TST is highly predictive of death among children with active TB. In children with clinical and radiographic findings suggestive of TB, a negative TST should not preclude or delay anti-TB therapy.
OBJECTIVE: We examined factors associated with in-hospital death among children with tuberculosis (TB). We hypothesized that a negative response to tuberculin skin testing (TST) would predict decreased survival. METHODS: This retrospective cohort comprised 2392 children ages 0 to 14 years hospitalized with TB at a Peruvian referral hospital over the 25-year study period. Detailed chart abstraction captured clinical history including TB contacts, physical examination findings, diagnostic data, treatment regimen, and hospitalization outcome. We used Cox proportional hazards regression analyses to determine risk factors for mortality. RESULTS: Of 2392 children, 2 (0.1%) were known to be HIV-positive, 5 (0.2%) had documented multidrug-resistant TB, and 266 (11%) died. The median time from hospitalization to death was 16 days (interquartile range: 4-44 days). Reaction of <5 mm induration on TST predicted death in a multivariable analysis (hazard ratio [HR]: 3.01; 95% confidence interval [CI]: 2.15-4.21; P < .0001). Younger age, period of admission, alteration of mental status (HR: 3.25; 95% CI: 2.48-4.27; P < .0001), respiratory distress (HR: 1.40; 95% CI: 1.07-1.83; P = .01), peripheral edema (HR: 1.97; 95% CI: 1.42-2.73; P < .0001), and hemoptysis (HR: 0.57; 95% CI: 0.32-1.00; P = .05) were associated with mortality. Treatment regimens that contained rifampicin (HR: 0.47; 95% CI: 0.33-0.68; P < .0001) were associated with improved survival. CONCLUSIONS: Negative reaction to TST is highly predictive of death among children with active TB. In children with clinical and radiographic findings suggestive of TB, a negative TST should not preclude or delay anti-TB therapy.
Authors: D K Kim; H J Kim; S-Y Kwon; H-I Yoon; C-T Lee; Y W Kim; H S Chung; S K Han; Y-S Shim; J-H Lee Journal: Eur Respir J Date: 2008-05-28 Impact factor: 16.671
Authors: R J Flick; M H Kim; K Simon; A Munthali; M C Hosseinipour; N E Rosenberg; P N Kazembe; J Mpunga; S Ahmed Journal: Int J Tuberc Lung Dis Date: 2016-08 Impact factor: 2.373
Authors: Suzanne T Anderson; Myrsini Kaforou; Andrew J Brent; Victoria J Wright; Lachlan J Coin; Robert S Heyderman; Michael Levin; Brian Eley; Claire M Banwell; George Chagaluka; Amelia C Crampin; Hazel M Dockrell; Neil French; Melissa S Hamilton; Martin L Hibberd; Florian Kern; Paul R Langford; Ling Ling; Rachel Mlotha; Tom H M Ottenhoff; Sandy Pienaar; Vashini Pillay; J Anthony G Scott; Hemed Twahir; Robert J Wilkinson Journal: N Engl J Med Date: 2014-05-01 Impact factor: 91.245
Authors: Kendra K Radtke; Kelly E Dooley; Peter J Dodd; Anthony J Garcia-Prats; Lindsay McKenna; Anneke C Hesseling; Radojka M Savic Journal: Lancet Child Adolesc Health Date: 2019-07-16
Authors: Augustine O Ebonyi; Stephen Oguche; Oche O Agbaji; Atiene S Sagay; Prosper I Okonkwo; John A Idoko; Phyllis J Kanki Journal: Germs Date: 2016-12-02
Authors: Argita D Salindri; Sara C Auld; Marcos C Schechter; Neel R Gandhi; Matthew J Magee Journal: Ann Epidemiol Date: 2019-02-27 Impact factor: 3.797
Authors: Muhammad Osman; Kevin Lee; Karen Du Preez; Rory Dunbar; Anneke C Hesseling; James A Seddon Journal: Clin Infect Dis Date: 2017-10-16 Impact factor: 9.079
Authors: Stephen M Graham; Charalambos Sismanidis; Heather J Menzies; Ben J Marais; Anne K Detjen; Robert E Black Journal: Lancet Date: 2014-03-24 Impact factor: 79.321